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Influence of border disease virus (BDV) on
serological surveillance within the bovine
virus diarrhea (BVD) eradication program
in Switzerland
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Abstract
Background: In 2008, a program to eradicate bovine virus diarrhea (BVD) in cattle in Switzerland was initiated. After
targeted elimination of persistently infected animals that represent the main virus reservoir, the absence of BVD is
surveilled serologically since 2012. In view of steadily decreasing pestivirus seroprevalence in the cattle population,
the susceptibility for (re-) infection by border disease (BD) virus mainly from small ruminants increases. Due to
serological cross-reactivity of pestiviruses, serological surveillance of BVD by ELISA does not distinguish between
BVD and BD virus as source of infection.
Results: In this work the cross-serum neutralisation test (SNT) procedure was adapted to the epidemiological
situation in Switzerland by the use of three pestiviruses, i.e., strains representing the subgenotype BVDV-1a,
BVDV-1h and BDSwiss-a, for adequate differentiation between BVDV and BDV. Thereby the BDV-seroprevalence in
seropositive cattle in Switzerland was determined for the first time. Out of 1,555 seropositive blood samples taken
from cattle in the frame of the surveillance program, a total of 104 samples (6.7%) reacted with significantly higher
titers against BDV than BVDV. These samples originated from 65 farms and encompassed 15 different cantons with
the highest BDV-seroprevalence found in Central Switzerland. On the base of epidemiological information collected
by questionnaire in case- and control farms, common housing of cattle and sheep was identified as the most
significant risk factor for BDV infection in cattle by logistic regression.
Conclusion: This indicates that pestiviruses from sheep should be considered as a source of infection of domestic
cattle and might well impede serological BVD surveillance.
Keywords: Bovine viral diarrhea virus (BVDV), Border disease virus (BDV), Pestivirus, Serum neutralisation test (SNT),
Seroprevalence, Small ruminants, Cross-neutralisation, Eradication, Risk factor
Background
The genus Pestivirus in the family Flaviviridae com-
prises the four established species border disease virus
(BDV), bovine viral diarrhea virus type-1 (BVDV-1),
bovine viral diarrhea virus type-2 (BVDV-2) and classical
swine fever virus (CSFV). Additional putative pestivirus
species were isolated from giraffe (“Giraffe-1 pestivirus”),
cattle (“atypical pestiviruses”), antelopes (“Pronghorn
antelope pestivirus ”) und piglets (“Bungowannah virus”)
[1–3]. Recently, an additional new strain termed
“atypical porcine pestivirus” was isolated from pigs and
piglets with congenital tremor [4, 5]. The ruminant
pestiviruses BVDV and BDV are important pathogens
with a worldwide distribution [6] causing substantial
economic losses in farm animal husbandry [7, 8].
Acute, transient infections of seronegative, immuno-
competent animals with ruminant pestiviruses are
frequently asymptomatic or are accompanied by mild
respiratory or enteric symptoms [9, 10]. By contrast,
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acute infection of pregnant cattle between approx. day
40 to 120 of gestation may cause transplacental trans-
mission of non-cytopathogenic (ncp) biotypes to the
fetus leading to the birth of persistently infected (PI)
calves. These animals shed virus life-long and, thereby,
comprise the primary pestivirus reservoir [11–13]. Simi-
larly, lambs persistently infected with border disease
virus caused by transplacental transmission display alter-
ations in their fleece and show tremor (hence there are
also called ‘hairy shakers’), and they may succumb by a
syndrome resembling Mucosal disease in cattle [14–17].
BDV in small ruminants occurs worldwide but with
very variable seroprevalence depending, e.g., on the
geographic location and the type of animal husbandry
[14, 17–20]. It was for the first time isolated in
Switzerland in a flock of sheep that gave birth to lambs
with generalized tremors and excessively hairy fleece in
2001 [21]. In a study published in 1995, seroprevalence
in registered sheep flocks of breeding associations and in
large flocks was around 20 and 65%, respectively [22].
More recent data pointed to a slightly lower seropreva-
lence of 13.5% [23] or 16.1% [18] in sheep and 25.4% in
goats [18]. In the latter study, it was demonstrated by
means of cross-serum neutralisation tests (cross-SNT)
that 9% of the sheep and 6% of the goats were
infected with BDV. However, 31% and 66% of the
seropositive sheep and goats, respectively, could not
be assigned to BVDV or BDV leaving the source of
infection unidentified.
Thus, even though broad serological cross-reactivity
occurs among pestiviruses, considerable quantitative
differences in neutralisation efficiency can be measured
by SNT between different species (also called genotype)
[24–26] and even subgenotypes [26–33]. To date, up to
21 (1a to 1u) and three (2a to 2c) subgenotypes were
described within the pestivirus species BVDV-1 and
BVDV-2, respectively [34, 35], mostly based on compari-
son of the 5′-UTR (untranslated region) or Npro (N-ter-
minal protease) region of the pestiviral genomes. In
Switzerland, BVDV-1e, -1h, -1k, and -1b are the most
prevalent subgenotypes identified in cattle, while BVDV-
2 was never detected [30, 36, 37]. Similarly, BD viruses
exhibit a large heterogeneity of strains [38] with 7 main
subgenotypes and several atypical BDV strains described
[39]. An additional phylogenetic group was detected in
our institute exclusively in Switzerland and provisionally
named BD Switzerland or BDSwiss [40, 41]. Lately, a
similar isolate was identified in Italy and labeled as
BDV-8 [42].
As ruminant pestiviruses are not strictly species
specific, they are able to infect a variety of even-toed
ungulates (Artiodactyla) [3, 13, 20]. Virus transmission
was described between cattle and both, sheep and goats
([19, 43, 44], and references therein). Natural infections
of cattle with BDV were reported in England and Wales
[45, 46], Austria [47, 48], Italy [49] and New Zealand
[50]. Common housing of cattle with persistently
infected sheep was the most important cause for
seroconversions, and resulted in reduced fertility and
abortions in pregnant cows [19, 44, 46]. BDV-specific
seroconversion in cattle was reported in Switzerland
after pasturing them with BDV-positive sheep on com-
mon alpine meadows [51].
Based on the economic impact of BVDV infections
in livestock, several European countries therefore ini-
tiated programs to eradicate BVDV in cattle [52, 53].
In Switzerland, such a program was started in 2008
that particularly targeted on a nationwide identifica-
tion and elimination of PI animals [54, 55]. Initially,
1.4% of all newborn calves were persistently infected
with BVDV, which dropped to less than 0.02% by the
end of 2012. From that time on, BVD control is
based predominantly on risk-based serological surveil-
lance of bulk milk and blood samples [56], with
continuously decreasing seroprevalence. As serology
performed by ELISA does not distinguish between an
infection with BVDV from one with BDV, the impact
of infection with BDV on serological surveillance on
BVDV is not known. Thus, the aim of this study was
to determine the frequency of BDV infections in cat-
tle by using an optimized cross-neutralisation SNT, to
identify potential risk factors for interspecies trans-
mission with special emphasis on small ruminants,
and to assess their possible influence on the sero-
logical surveillance of BVD in bovines.
Methods
Sera
Sera used in this study were from the period 2012 to
2014 and were initially rated as “indeterminate” or
“positive” to antibodies (Ab) against pestivirus by ELISA
performed by a primary laboratory and later confirmed
as positive by the national BVD reference laboratory
(Institute of Veterinary Virology/Institute of Virology
and Immunology, Bern, Switzerland). A serum was
confirmed as positive when it was either positive in the
institutes “in house”-ELISA [57] or when it was rated
positive in a serum neutralisation test (SNT) using
BVDV-1a (Table 1) as challenge virus. Sera were only
included if they were obtained from animals that were at
least 6 months old at the time of sampling and that were
born later than Sept. 30, 2009, i.e., after phase 2 of the
Swiss BVD eradication program [58]. If several samples
from the same animal were obtained, only the one that
was analysed first in the reference laboratory was used
for the analysis. All sera were stored at -20 °C prior to
use. Overall, 1,568 sera fulfilled the criteria mentioned
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above, with 506, 536, and 526 sera obtained in the years
2012, 2013, and 2014, respectively.
Cells
Bovine turbinate (BT) cells were prepared at the Institute
of Veterinary Virology (University of Bern, Switzerland)
from bovine fetuses obtained from a local abattoir and
were maintained in Earle’s minimal essential medium
(E-MEM; Biochrom GmbH, Berlin, Germany) supple-
mented with 15% fetal calf serum (FCS) (2% during
experiments), 100 U/ml penicillin, and 100 μg/ml strepto-
mycin at 37 °C in a humidified 5% CO2 atmosphere. FCS
was free of pestivirus and antibodies to BVDV/BDV as
tested by virus isolation and SNT, respectively. BT cells
were found to be free of pestivirus by immunoperoxidase
staining, and they were used to produce virus stocks, and
to perform SNTs and virus (back-)titrations.
Production of challenge viruses used for SNT
Overall, 10 strains of ruminant pestiviruses from differ-
ent subgenotypes were selected as challenge virus for
the SNT (4× BDV, 5× BVDV-1 and 1× BVDV-2)
(Table 1). All major subgenotypes hitherto isolated in
Switzerland were represented by one isolate (BDSwiss-a,
BDSwiss-b, BDV-3 and BVDV-1h, -1e, -1k, -1b) [37, 40].
With the exception of the North American strain
Oregon C24 (R1935/72, BVDV-1a, [59]), all isolates were
of the non-cytopathogenic (ncp) biotype. Each isolate
was propagated in 150 cm2 cell culture flasks (TPP AG,
Trasadingen, Switzerland) seeded with 3 × 106 BT cells
in 50 ml E-MEM with 15% FCS. One day post-seeding,
the cells were infected for 1 h at a multiplicity of infec-
tion (moi) of 0.01 in 10 ml E-MEM with 7% FCS
followed by the addition of 40 ml of E-MEM with 7%
FCS. Cell infected with an ncp biotype of pestivirus were
further incubated for 5 days at 37 °C and 5% CO2,
whereas the cells infected with the cytopathogenic (cp)
BVDV-1a strain were harvested at the time when 80% of
the cells showed signs of cytopathic effect (CPE) as
judged by light microscopy. Virus stocks were obtained
by freeze-thawing the cells at -20 °C and removal of cell
debris by centrifugation for 15 min at 10,000g (HiCen®
21C, Hemotec GmbH, Gelterkinden, Switzerland).
Aliquots of 0.5 ml were stored at -80 °C until use.
Homologous sera
For each of the 10 subgenotypes, a serum as homolo-
gous as possible was chosen. Eight out of 10 sera were
Swiss field sera, whereas the immune sera to the geno-
types BVDV-1a (strain R1935/72) and BVDV-2 were ob-
tained from vaccine trials in Switzerland and Germany,
respectively. The latter was raised against the BVDV-2
strain CS8644 [60] and was kindly provided by G. Wolf
(LMU, Munich, Germany). For the subgenotype BDV-1a
that was never detected in Switzerland to date, no hom-
ologous serum was available and, thus, we used a field
serum from an antibody-positive heifer with unknown
source of infection that displayed a rather high titer
against BDV-1a. All sera were stored at -20 °C.
Serum neutralisation test
For the detection and quantification of pestivirus-
specific neutralising antibodies in cattle sera, a serum
neutralisation test (SNT), which is considered the gold
standard in BVDV serology [61, 62], was developed and
optimized for the current situation in Switzerland. Basic-
ally, the SNT was done according to the directions of
the OIE [63]. Briefly, sera to be tested were pre-diluted
tenfold in E-MEM with 2% FCS and inactivated for 30
min at 56 °C. In the cases were only an insufficient
amount of serum was available for all experiments, the
serum was pre-diluted 20- (n = 46) or 40-fold (n = 6).
Table 1 Ruminant pestivirus isolates selected for SNT
Pestivirus Subgenotype Isolate Species Sourced Reference
BDV Swiss-a R9336/11 Cattle IVV/IVI BE [40]
BDV Swiss-b R4785/06/CH-BD4 Sheep IVV/IVI BE [44]
BDV 3 R1343/01/CH-BD1 Sheep IVV/IVI BE [36]
BDV 1a Moredun Sheep P. Nettletona [72]
BVDV-1 1h CH-04-01b Cattle IVV/IVI BE [30]
BVDV-1 1e CH-Maria Cattle IVV/IVI BE [30]
BVDV-1 1k CH-Suwa (ncp)c Cattle IVV/IVI BE [30]
BVDV-1 1b CH-04-05 Cattle IVV/IVI BE [30]
BVDV-1 1a R1935/72 (cp)c Cattle IVV/IVI BE [59]
BVDV-2 2a 890 Cattle J. F. Ridpathb [73]
aMoredun Research Institute, Edinburgh, Scotland
bNational Animal Disease Center, Ames IA, USA
ccp cytopathogenic, ncp non-cytopathogenic
dIVV/IVI BE = Institute of Veterinary Virology/Institute of Virology and Immunology, Bern
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Thereafter, sera were further diluted seven times in two-
fold steps up to a dilution of 1 in 1,280. Dilutions were
directly done in 96-well plates with 4 wells per dilution
and in a volume of 50 μl of serum per well. Afterwards,
100 tissue culture infectious dose 50 (TCID50) of
challenge virus in 50 μl E-MEM with 2% FCS per well
were added and the plates were incubated for one hour
at 37 °C in a humidified 5% CO2 atmosphere. Subse-
quently, a cell suspension in E-MEM with 2% FCS with
20,000 cells in a volume of 100 μl was added to each
well and further incubated for 4 to 5 days. For each ex-
periment, a positive (α-BVDV-1b) and a negative control
serum was included, and to control for possible serum
cytotoxicity, 50 μl of serum of the first pre-dilution was
added to another well in the absence of challenge virus.
For evaluation of the ncp strains, immunoperoxidase
staining was performed, whereas the neutralisation of
the cp strain was directly quantified by analysis of the
CPE by light microscopy. The neutralisation titer
was calculated according to Spearman-Kaerber and
expressed as reciprocal value of the dilution required
for 50% of the wells exhibiting neutralisation of the
challenge virus. Samples with a titer greater than 8
were rated as positive.
In order to differentiate the source of infection, we
performed cross-neutralisation tests using different strains
of ruminant pestiviruses as challenge virus in parallel
SNTs. To identify the strains with the best discriminatory
power, we screened various combinations of BVDV and
BDV as challenge virus, whereby an at least fourfold differ-
ence of their SNT titers were regarded as significant [63].
Taking the samples with low volume (20-fold pre-dilution)
into account, sera with BVDV and BDV titers lower
than 15 were regarded as negative. A ratio of the
BVDV- and BDV-titer of lower than 4 was considered
as “indeterminate”.
Virus titration
Virus titrations were performed according to the direction
of the OIE [63]. Briefly, the virus suspensions were diluted
seven times in tenfold steps in E-MEM with 2% FCS
directly in 96-well plates with 6 wells per dilution using a
volume of 50 μl per well. Six wells were used as cell con-
trol with the simple addition of medium. After addition of
the cell suspension (20,000 cells per well in 100 μl E-
MEM with 2% FCS), the plates were incubated for 4 to 5
days at 37 °C in a humidified 5% CO2 atmosphere. Virus
titers were calculated according to Spearman-Kaerber and
presented as tissue culture infectious dose 50
(TCID50) per ml. In every SNT, the amount of chal-
lenge virus applied (100 TCID50) was controlled by
back-titration in parallel to the SNT, and a variation
of half a log level was considered as acceptable
(101.5–102.5 TCID50 = 32 to 316) [63]. SNTs with the
back-titration being outside of this range were
repeated.
Immunoperoxidase staining
An immunoperoxidase staining was applied for cells
infected with an ncp biotype of pestivirus. Cells were
washed with PBS and subsequently thoroughly dried for
at least one hour in the air flow of a safety cabinet.
Thereafter, cells were fixed and permeabilised by incuba-
tion for two hours at 80 °C. After the plates regained
room temperature, the primary antibody (polyclonal
swine-α-BVDV hyperimmune serum prepared at the
Institute of Veterinary Virology, University of Bern) was
applied at a dilution of 1 to 750 in PBS with 5% Tween-
20 (PBS-T) and incubated for 90 min at ambient
temperature. After washing the cells three times with
PBS-T, the secondary antibody (monoclonal peroxidase-
labeled goat-α-swine IgG; KPL, Gaithersburg, MD, USA)
at a dilution of 1 to 1,000 in PBS-T with 5% low-fat
powdered milk was applied for 90 min at room
temperature. Subsequently, cells were washed twice with
PBS-T and once with distilled water, followed by the
addition of the substrate solution (0.4 mg/ml 3-Amino-
9-ethylcarbazole (AEC), 6% dimethylformamide, 0.3‰
H2O2 in 0.05 M sodium acetate at pH 5.0) and incuba-
tion for approx. 30 min until an adequate staining was
observed. Staining was stopped by washing the cells with
distilled water.
Case-control-study
In order to detect risk factors for infection with border
disease virus in livestock, we performed a retrospective
case-control-study in farms whose young stock was
surveyed serologically in the BVD eradication program
in Switzerland and the Principality of Liechtenstein [64].
Young stocks are used for sero-surveillance in non-dairy
herds. Each year, a random sample of one third of all
farms that did not have a PI animal within the last 24
months, and all herds that either had a PI animal or a
conspicuous result in bulk milk testing within this time
period, are tested serologically. A group of young
stock is tested that consists of 5 calves within a herd
of an age of at least 6 months, which were born later
than September 30, 2009 and more than one month
after the removal of the last known PI animal from
the farm. In addition, these calves should have stayed
on a given farm for at least 6 months and not previ-
ously had a known contact with a PI animal. Based
on these criteria, 54 farms with at least two seroposi-
tive animals in the time interval from February 2014
to June 2015 were selected as potential case farms.
Sera from such potential case farms were tested in
the cross-SNT, and the farm was considered a definite
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case farm if the herd contained at least one single
seropositive animal that was rated as infected with
BDV. Potential case farms which proved negative for
BDV in the cross-SNT were excluded. Control farms
were selected out of a pool of 10,753 farms (data col-
lection by the Swiss Veterinary Service) that were
never tested seropositive for BVDV since the start of
the eradication program in 2008 and that had tested
at least 5 animals as seronegative since the beginning
of 2012. Control farms were selected using the Swiss
animal movement database [56]. Because only 16
definitive case farms that also returned the question-
naire (see below) could be identified, the number of
controls was increased to reach a relation of at least
three controls per case.
Data acquisition
To identify potential risk factors for the occurrence of
BDV infections in cattle, variables such as presence of
small ruminants, herd size, use and distribution of breed,
animal movement (summer pasturing), common hous-
ing and pasture management, and external contact to
(wild) ruminants, were collected by a standardized,
bipartite questionnaire for cattle farmers. The first part
of the questionnaire contained a total of 55 questions
regarding the farm itself, contacts to animals on
neighboring farms, or purchase and sale (animal
movement) with special emphasis on possible direct
and indirect exposure to small ruminants. The second
part mainly aimed at receiving information on the
origin of seropositive and seronegative animals in case
and control farms, respectively. Additionally, informa-
tion on the breeds of the animals was obtained from
the animal movement database. The questionnaires
were issued in German, French and Italian, and were
distributed to the Cantonal Veterinary Services start-
ing in the middle of August 2014. Official veterinar-
ians or the farm veterinarians were instructed by the
Cantonal Veterinary Services to perform the inter-
views that were conducted on-site or by phone.
Statistics
Data of the SNTs and the questionnaires were entered
into the spreadsheet Excel® 2010 (Microsoft Corporation).
The frequency distribution of the different potential
risk factors in the 37 case and 280 control animals
from 16 case and 56 control farms were statistically
compared using the Chi-Square test for categorical
variables and with the two-sample t-Test for normally
distributed continuous variables, whereas the Mann-
Whitney-U-Test was used for not normally distributed
variables. After the univariable analysis of each indi-
vidual risk factor according to the questionnaire, a
multivariable logistic regression model with the
potential risk factors (p < 0.1) was developed. In the
model, clustering on the level of the farm was cor-
rected with the GEE (generalized estimating equation)
method [65]. None of the 13 identified potential risk
factors were highly correlated with each other (correl-
ation coefficient <0.7), therefore all of them were
offered to the model. The final model was established
by stepwise forward selection of the risk factors, until
only significant factors (p < 0.05) and confounders
remained in the model. Risk factors were considered
as confounders and kept in the model if they altered
the regression coefficient of another risk factor by
more than 25%. The univariable and multivariable
statistical analysis of the data was performed with
NCSS (version 9; NCSS LLC, Kaysville UT) and with
PROC GENMOD in SAS (version 9.4; SAS Institute
Inc., Cary NC), respectively. Model fit was assessed
with QIC and QICu fit criteria, as well as with visual
assessment of the residuals.
Results
Distribution of field sera
Around three quarters (74.8%) of the 1,568 con-
firmed antibody-positive sera (see Methods section)
were from cattle that were born prior to 2012 with
44% (n = 512) thereof in the year 2010. Animals at
the age of 6 to 11 months at the time of examination
represented the largest age group (n = 347, 22.1%)
which is in accordance with the specifications of the
«spot test» [55]. Overall, samples from 24 out of the
26 Swiss (half-) cantons and of the Principality of
Liechtenstein were at our disposition, and the sample
distribution was in good agreement (Fig. 1) with the cattle
density per km2 per locality (based on postal code) in
Switzerland.
Cross-neutralisation of the selected BDV and BVD strains
For the selection of the most appropriate BD and
BVD virus strains to be used in the cross-SNT, we tested
all possible combinations of the 10 isolates of ruminant
pestiviruses (BDV, BVDV-1, BVDV-2; Table 1). For each
subgenotype, we selected a serum as homologous as pos-
sible and titrated them in the SNT with all the pestivirus
strains (see Additional file 1: Table S1). With only
few exceptions, the highest titers were detected with
the homologues pairs of virus and serum. The highest
titer of 5,120 was observed with the anti-BVDV-1e
serum and the corresponding virus strain CH-Maria.
The only exceptions were the sera raised against
BDSwiss-a, BDV-1a, and BVDV-1k, which reacted
equally or even stronger in response to other virus
isolates than their homologous virus strain. As ex-
pected [26, 66], the anti-BVDV-2a serum exhibited a
low (average titer = 48) and a medium (average titer = 135)
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neutralisation reactivity against BDV and BVDV-1, re-
spectively. Conversely, the anti-BDV sera poorly (mean
titer = 19) and moderately (mean titer = 164) neutralized
the BVDV-2a strain 890 and the BVDV-1 strains, respect-
ively. All BVDV-1 sera except the one directed against
BVDV-1h only weakly neutralized BD viruses (mean
titer = 47), whereas their cross-neutralisation was
rather high against heterologous BVDV-1 strains
(mean titer = 523). Finally, sera directed against BDV
showed a low and medium neutralisation activity to-
wards BVDV-1 strains (mean titer = 57) and heterol-
ogous BD viruses (mean titer = 192), respectively.
Coefficients of antigenic similarity (R)
The antigenic relatedness of a pair of viruses was
determined by calculating the coefficient of antigenic
similarity (R) [67] according to the following formula:
R ¼ 100

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
titer virus isolate A with serum B  titer virus isolate B with serum A
titer virus isolate A with serum A  titer virus isolate B with serum B
r
A value of R ≤ 25 is considered to denote a significant
antigenic difference between the virus strains [24, 30].
All possible combinations of BD and BVD viruses
displayed an R-value lower than 25, which is indicative
of a significant antigenic difference between two strains.
The largest differences with R-values lower than two
were observed between BDV and BVDV-1 strains,
whereas the four strains of BDV displayed the highest R-
values among each other (Table 2) with no significant
difference between any two strains.
Selection of the pestivirus strains used in cross-
neutralisation of field sera
The quotients of titers of the cross-neutralisation assays
of the 10 sera with the four BD and the six BVD viruses
were calculated for all possible pairwise combinations
(Table 3), with the absolute numbers of the SN titers
listed in supplementary Additional file 1: Table S1.
Values of the quotient below 4 were considered as
indeterminate. All antisera against BDV were correctly
assigned with 4 different combinations of virus pairs
(BVDV-1a and BDSwiss-a; BVDV-2a and BDSwiss-a or
BDSwiss-b; BVDV-1k and BDSwiss-a). The six BVDV
antisera were correctly classified in three pairwise com-
binations of the subgenotype BVDV-1h, e.g., with the
strains BDSwiss-a, BDSwiss-b and BDV-3. Overall, the
virus pair BVDV-1a and BDSwiss-a displayed the best
differentiation of all sera, with correct classification of 8
out of 10 sera in the cross-neutralisation assays. By adding
the results of the BVDV-1h strain CH-04-01b in combin-
ation with the BDV strain Swiss-a, both remaining BVD-
antisera (anti-BVDV-1h and anti-BVDV-2) could be prop-
erly assigned. Therefore, the pestivirus strains BVDV-1a,
BVDV-1h and BDSwiss-a were selected as being optimally
suited for the differentiation between BVDV and BDV as
source of infection in the current epidemiological situ-
ation in Switzerland.
Fig. 1 Geographic distribution of field sera and density of the cattle population in Switzerland and of the Principality of Liechtenstein (LI). The
map was created with the geographic information system QGIS 2.8.1-Wien. The number of cattle per ZIP (postal code; data 2014) were obtained
from the Swiss Federal Statistical Office (https://www.pxweb.bfs.admin.ch); n (Farms providing sera) = 898
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Table 3 Ratios of the cross-SNT titers of 10 sera tested with all combinations of BDV and BVDV isolates
Sera Virus pair
BVDV-1h BVDV-1e BVDV-1k
BD Swiss-a BD Swiss-b BDV-3 BDV-1a BD Swiss-a BD Swiss-b BDV-3 BDV-1a BD Swiss-a BD Swiss-b BDV-3 BDV-1a
α-BDSwiss-a 4.4 4.4 1.9 2.0 5.1 5.1 2.2 2.4 8.8 8.8 3.7 4.1
α-BDSwiss-b 4.0 a 6.7 1.8 2.2 5.6 9.5 2.6 3.1 8.8 14.7 4.0 4.8
α-BDV-3 1.1 0.9 2.8 0.9 1.5 1.3 4.0 1.3 4.4 3.7 11.4 3.7
α-BDV-1a 1.7 2.6 1.7 1.5 3.1 4.8 3.1 2.8 11.4 17.6 11.4 10.5
α-BVDV-1h 6.2 14.7 16.0 16.0 0.6 1.5 1.7 1.7 0.5 1.1 1.2 1.2
α-BVDV-1e 64.6 60.3 32.3 26.6 365.7 341.3 182.9 150.6 11.4 10.7 5.7 4.7
α-BVDV-1k 22.7 6.8 13.3 6.2 10.4 3.1 6.1 2.8 6.2 1.8 3.6 1.7
α-BVDV-1b 22.7 19.0 26.7 16.0 10.4 8.7 12.2 7.3 4.8 4.0 5.6 3.4
α-BVDV-1a 38.1 10.4 15.9 24.5 17.5 4.8 7.3 11.3 19.1 5.2 7.9 12.3
α-BVDV-2a 8.0 4.3 8.0 3.4 7.3 4.0a 7.3 3.1 1.7 0.9 1.7 0.7
Sera Virus pair
BVDV-1b BVDV-1a BVDV-2a
BD Swiss-a BD Swiss-b BDV-3 BDV-1a BD Swiss-a BD Swiss-b BDV-3 BDV-1a BD Swiss-a BD Swiss-b BDV-3 BDV-1a
α-BDSwiss-a 5.1 5.1 2.2 2.4 8.8 8.8 3.7 4.1 8.2 8.2 3.5 3.8
α-BDSwiss-b 4.3 7.3 2.0 2.4 34.5 58.1 15.8 18.8 22.6 38.0 10.3 12.3
α-BDV-3 2.0 1.7 5.2 1.7 4.4 3.7 11.4 3.7 6.2 5.2 16.0 5.2
α-BDV-1a 2.0 3.1 2.0 1.8 11.4 17.6 11.4 10.5 10.7 16.5 10.7 9.8
α-BVDV-1h 1.5 3.7 4.0 4.0 0.6 1.4 1.5 1.5 0.5 1.3 1.4 1.4
α-BVDV-1e 32.4 30.2 16.2 13.3 24.9 23.3 12.5 10.3 11.4 10.7 5.7 4.7
α-BVDV-1k 19.1 5.7 11.2 5.2 6.2 1.8 3.6 1.7 2.6 0.8 1.5 0.7
α-BVDV-1b 54.0 45.3 63.5 38.1 8.0 6.7 9.4 5.7 3.7 3.1 4.3 2.6
α-BVDV-1a 69.8 19.1 29.1 45.0 234.8 64.3 97.8 151.5 5.7 1.5 2.4 3.6
α-BVDV-2a 2.0 1.1 2.0 0.8 2.8 1.5 2.8 1.2 53.5 29.1 53.5 22.7
For the calculation of the ratios of the α-BD sera, the titer of BDV was taken as numerator and the titer of BVDV as denominator. For the calculation of the ratios
of the α-BVD sera the reverse ratio was used. Ratios < 4 are highlighted in bold
aThe exact value was slightly below 4.0
Table 2 Coefficients of antigenic similarity (R) between BDV and BVDV isolates
BDV & BVDV isolates BDV Swiss-a BDV Swiss-b BDV−3 BDV-1a BVDV−1h BVDV−1e BVDV−1k BVDV−1b BVDV−1a BVDV−2a
BDSwiss-a 100 77.1 40.3 71.0 19.2 ≤ 2.3 ≤ 13.6 6.0 ≤ 2.2 4.8
BDSwiss-b 100 29.8 73.8 10.1 1.8 19.2 5.5 1.6 3.0
BDV-3 100 59.5 14.8 3.7 15.6 5.5 3.0 3.4
BDV-1a 100 20.1 4.8 ≤ 23.8 12.0 2.5 6.7
BVDV-1h 100 13.6 52.3 32.4 12.5 11.5
BVDV-1e 100 22.9 13.1 7.1 6.5
BVDV-1k 100 52.3 28.5 11.5
BVDV-1b 100 21.0 5.0
BVDV-1a 100 3.6
BVDV-2a 100
R-Values ≤ 25 indicate significant antigenic differences between two isolates (in italics). For nondescript titers (≤ 14), the value of 14 was taken for calculation and,
accordingly, the R-values are marked with “≤”
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Neutralisation and cross-neutralisation of field sera
In order to differentiate BVDV and BDV as source of
infection, we employed the cross-SNT with the three
challenge strains BVDV-1a, BVDV-1h, and BDSwiss-a as
described above. From 1,568 samples that were initially
confirmed to be positive for pestivirus antibodies and
that originated from 898 farms, we were able to analyze
1,555 in the cross-SNT. This includes the six results to
the BVDV-1a strain from the initial SNT that was
applied by the reference laboratory for samples where
not sufficient material was available to perform full
cross-neutralisation.
Both, the average titer (geometric mean titer (GMT) =
346.3; median = 495.5) of the field sera and the neutral-
isation titer of the majority of the individual samples
(1,394 out of 1,549 samples) were higher towards the
BVDV-1h isolate than the ones towards the BVDV-1a
strain (GMT = 125.5; median = 135). The average
(GMT = 74.8; median = 80) as well as most of the
single titers to BDSwiss-a were clearly lower than the
values to the BVD viruses (Fig. 2a). The highest titer
(≥1,810) was reached with 153, 14, and one sera
against BVDV-1h, BVDV-1a, and BDV, respectively.
Most sera with negative neutralisation titers (≤ 8)
were observed using BDV in the SNT (n = 257).
Identification of the source of infection by cross-SNT
By combining the results of the SNTs with the virus
strains of the subgenotype BVDV-1a and BDSwiss-a, we
were able to differentiate the source of infection between
BVDV and BDV in 550 out of 1,555 samples (35.4%). By
adding the BVD/BD-quotient with the BVDV-1h strain
to the remaining samples (i.e., 870 samples that could
not be assigned using only the BVDV-1a strain, and to
135 samples that were rated as negative), further 666
sera could be sourced to an infection with BVDV
(Table 4). In 93% of all BVD-positive cases, the sera had
a higher titer towards BVDV-1h than BVDV-1a. Con-
versely, for samples that were assigned to an infection
with BDV, their low reactivity towards the BVDV-1a
strain was pivotal for their differentiation from BVDV
(Fig. 2b). In no instance a contradictory combination of
the results was observed. Overall, the majority of sam-
ples were assigned to BVD (n = 1,112, 71.5%; CI 95%:
69.2–73.7%), and only 104 cattle sera (6.7%; CI 95%:
5.5–8.0%) were attributed to an infection with BDV. In
28 samples that could initially not be differentiated be-
cause they still exhibit full neutralisation even at the
highest dilution, repetition of the experiments with more
dilutions steps allowed their differentiation to an infec-
tion with BVDV (n = 27) or BDV (n = 1). The remaining
sera could either not be differentiated (n = 286, 18.4%;
CI 95%: 16.5–20.4%) or were regarded as negative
(n = 53, 3.4%; CI 95% 2.6–4.4%) based on their low
titers (titers ≤ 14).
BDV as source of infection: distribution of samples
The 104 cattle sera that were assigned to BDV as source
of infection originated from 65 farms within 15 cantons
(Fig. 3). A large part of the samples came from Central
Switzerland (n = 36), in accordance with the observation
that the two cantons with the highest prevalence of
Fig. 2 Distribution of SNT titers of sera against BVDV-1a, BVDV-1h and BDV. a The box plots of titers of positive sera were created with the
statistical software NCSS 9. Only positive titers (> 8) were included (nBVDV-1a = 1,400; nBVDV-1h = 1,496; nBDV = 1,292). For titers with a value of ≤ 14
(20-fold pre-dilution), ≤ 28 (40-fold pre-dilution) and≥ 1,810, the values 14, 28 and 1,810 were taken for calculation, respectively. The SNT titers
are represented in the y-axis as logarithm to the base 2 including the standard 5-fold pre-dilution, i.e., multiplication with 5 yields the final titer.
b The scatter plot of the sera samples (n = 1,555) based on their titers against BDSwiss-a, BVDV-1a and BVDV-1h was created with the statistical
software NCSS 9. The black dotted line represents the threefold rotational axis on which each of the three titers per sample would have the same
value and, therefore, no assignment to “BVD” or “BD” is possible (yellow). BDV-specific sera with low reaction against BVDV-1a are located in the
upper left section of the cube (red), whereas BVDV-specific sera with high reaction against BVDV-1h are located in the lower right section of the
cube (green). Negative sera are in the lower left corner (purple)
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BDV-reactive sera (64.7 and 32.4%) were from this area.
Notably, in three of these farms in Central Switzerland,
calves that were persistently infected with BDV were
detected within the scope of the Swiss BVD eradication
program (H.P. Stalder, personal communication and [37]).
In 9 cantons and in the Principality of Liechtenstein, we
could not detect any BDV positive sample within the 206
sera that we analyzed.
In 21 out of 29 farms where a BDV-specific sample
and more than one positive serum in the cross-SNT was
obtained, all of the samples were specific for BDV as
source of infection. From the remaining farms, four had
samples that could not be differentiated or were nega-
tive, whereas in the other four, BVDV could also be
identified as source, sometimes in combination with
indeterminate samples.
Table 4 Combinations of results from the cross-SNT tested with 3 isolates
Evaluation with BVDV-1a & BDV Evaluation with BVDV-1h & BDV Assignmenta n = Percentage of combination
per assignment [%]
Proportion overall [%]
BVD & BVD BVD 428 38.5 71.5
BVD & Negative 4 0.4
BVD & Indeterminate 13 1.2
Indeterminate & BVD 594 53.5
Negative & BVD 72 6.5
BVD n.d.b 1 0.1
BD & BD BD 68 65.4 6.7
BD & Indeterminate 32 30.8
BD n.d.b 1 3.8
Indeterminate & Indeterminate Indeterminate 276 96.5 18.4
Negative & Indeterminate 10 3.5
Negative & Negative Negative 52 98.1 3.4
Negative n.d.b 1 1.9
Total 1,555 100
aSera with a ratio of ≥ 4 were assigned as “BVD” or “BD”, sera with a ratio < 4 were “indeterminate”, and sera with both titers < 15 are “negative”
bn.d not done, due to insufficient amount of material
Fig. 3 Farms with BDV-positive sera and case and control farms in Switzerland and the Principality of Liechtenstein (LI). The location of farms with
BDV-positive sera (circles) including the definitive case farms (triangle) and the control farms (squares) are presented. The number of BDV-specific
sera from one to four is displayed by a color gradient from yellow to red as indicated in the figure
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According to information retrieved from the Swiss
animal movement database [58], small ruminants
were present on 44 farms (68%) where BDV was
identified as source of infection in at least one sam-
ple. Thereof, 27 (61%) of these farms housed sheep, 4
(9%) goats, and 13 (30%) both, sheep and goats. By
contrast, only a third of the farms without BDV-
positive samples (n = 259, 31%) kept small ruminants
according to information obtained from the animal
movement database.
Selection of farms for the case-control-study
We obtained detailed data on 54 potential case farms
that were recruited between February 2014 and June
2015 based on the serological screening results using a
standardized questionnaire. BDV was later identified by
means of cross-SNT as the source of infection in 37
samples from 16 farms that were distributed across 7
cantons and the Principality of Liechtenstein (Fig. 3).
Additional 3 samples from these definitive case farms
were indeterminate and one was negative. In no case
farm could we detect any BVDV-specific serum.
Descriptive, univariable statistics
By means of Pearsons’s chi square test, we identified
significant differences (p < 0.1) in 9 out of 50 categorical
variables and, using Mann-Whitney-U-test or t-test,
in 4 out of 5 continuous variables (Additional file 2:
Table S2a and S2b). The variables sheep farming,
sheep breed, and origin of cattle display the lowest p values
(p < 0.0001). Within the continuous variables, the number
of cattle was considerably (p = 0.0006) and the number of
sheep, goats, and loss of lambs was fairly different (p = 0.1)
between the case and control groups (Additional file 3:
Table S3).
Logistic regression
Variables that were significant according to the univari-
able analysis and additional variables of epidemiological
relevance regarding animal movement (purchase, prov-
enance) were introduced into the model of logistic re-
gression by stepwise forward selection. At the farm level,
the risk factors “same stable” (sheep and cattle are kept
in the same stable; OR (odds ratio) = 167.23, CI95%:
15.37–1,819.29, p < 0.0001) and “cattle purchase” (pur-
chase of cattle within the last 12 months; OR = 9.57,
CI95%: 1.08–84.95; p = 0.0426), and at the level of the indi-
vidual animal, the risk factor “cattle provenance” (cattle
was purchased; OR = 4.16, CI95%: 1.64–10.60; p = 0.0028)
could be confirmed as significant in the final model.
Discussion
In this study, we investigated the frequency of BDV in-
fections in cattle and evaluated their possible influence
on the serological surveillance in the Swiss BVD eradica-
tion program. Thus, we selected one strain out of each
major subgenotype of ruminant pestiviruses detected in
Switzerland so far [37] in addition to the two strains pre-
viously used for differentiation in routine diagnostic, i.e.,
R1935/72 (BVDV-1a) and Moredun (BDV-1a). In order
to choose the most appropriate challenge viruses in the
cross-SNT to differentiate BVDV from BDV infections,
all possible pairwise combinations out of the 6 BVDV
and 4 BDV strains were tested (Table 1) together with
sera that were as homologous as possible to the corre-
sponding virus isolates. The combination of BVDV-1a
and BDSwiss-a turned out to be an optimal combination
that correctly assigned 8 out of 10 test sera (Table 3), in-
cluding all BDV-specific samples, and that yielded the
highest ratios of the neutralisation titers (mean = 33.6).
In addition, by analyzing the effect of varying the dose
of challenge virus employed in the SNT (102 TCID50 ±
0.5 log as acceptable range for the challenge viruses) on
the SN titers essentially confirmed the usefulness of a
quotient of four used in classic serology as a threshold
for significance (not shown). And notably, the use of
cytopathogenic strains such as the strain R1935 (BVDV-
1a) was advantageous as it allowed for direct microscop-
ical evaluation of the results. In field situations, however,
only non-cytopathogenic strains are available and, thus,
the need for fixation and immunostaining of the cells
cannot be avoided.
In contrast to the test sera, the combination of BVDV-
1a and BDSwiss-a was not able to differentiate between
BVDV and BDV as the source of infection in more than
half of the field sera (55.9%) (Table 4). In addition to the
BVDV-1a subgenotype, which was never found to circu-
late in Switzerland, we thus included a strain of the in
our country most commonly found genotype BVDV-1h
[30, 37] into the analysis. Using these three strains as
challenge viruses in the cross-SNT, we were able to
diminish the rate of indeterminate samples to 18.4%. As
a result, we could considerably improve the former
triage which was used in the laboratory that applied only
two strains (BVDV-1a and BDV-1a Moredun) and that
was thus unable to assign 31.0 and 66.4% of the sheep
and goat sera, respectively [18]. In the case of a BVDV
infection, we generally observed higher neutralisation ti-
ters against the challenge virus BVDV-1h than towards
BVDV-1a, which is based on the higher antigenic
homology of the field sera to a strain circulating in the
Swiss cattle population. But the exclusive use of the
BVDV-1h strain in combination with BDSwiss-a was not
favorable as it only poorly identified BDV infections.
Based on the quotients of the neutralisation titers
observed (Table 3), further reduction of the number of
indeterminate sera proved to be difficult. In case of acute
infections in the field, direct virus isolation and partial
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sequencing of the viral genome would be required [37].
Nonetheless, the adaptation of the serological triage
system to the current epidemiological situation proved
to be an important prerequisite for optimal selectivity to
differentiate between ruminant pestivirus infections.
A small number of samples (3.4%) that were initially
confirmed to be antibody positive by ELISA could not
be confirmed in the cross-SNT (Table 4). In spite of the
significant correlation between the SNT and the ELISA
results (not shown), the two assays are inherently differ-
ent. Thus, the epitopes important for the neutralisation
assay are mainly part of the E2 envelope glycoprotein in
its native conformation, whereas the “in-house” ELISA
detects primarily antibodies directed to the conserved
non-structural protein NS2-3 [57, 62, 68].
The results of the cross-SNTs comprising the three
challenge viruses BVDV-1a, BVDV-1h, and BDSwiss-a,
clearly demonstrated that the majority of pestivirus in-
fections in cattle discovered 4 to 7 years after the start of
the eradication can be ascribed to BVDV (71.5%),
whereas only 6.7% were caused by infections with BD vi-
ruses. Nevertheless, it has to be considered that at least
some of the indeterminate sera (18.4%) might also have
BDV as source of infection. The BDV seroprevalence
within the pestivirus-antibody positive animals slightly
increased between 2012 and 2014 from 4.2 to 8.1%
(not shown), whereas the overall seroprevalence in
the Swiss cattle population continuously decreases
[69]. These results point to a potential interference by
small ruminants, in particular sheep, with the eradication
of BVDV from cattle. Interestingly, small ruminants were
kept – according to the entries in the animal movement
database – on all case farms and on the majority of farms
where BDV infections were detected by serology, with
sheep being more prominent than goats. Notably, sheep
flocks with more than 100 animals were exclusively found
within the case farms. The highest portion of BDV-
specific sera (n = 36; 34.6%) as well as the highest BDV
seroprevalence (19% of all seropositive samples) were ob-
tained from Central Switzerland (Fig. 3) while the number
of animals and of samples in this region are within average
of all greater areas of Switzerland (Fig. 1).
By means of a logistic regression model to determine
the influence of potential risk factors for an infection
with BDV, we provided evidence for the impact of small
ruminants. Common indoor housing of sheep and cattle
was identified as the risk factor with the highest odds
ratio in the final model (OR = 167.23). Further variables
with significant but smaller influence were the purchase
of cattle on the level of the farm (purchase within the
last 12 month) (OR = 9.57) and on the level of the
individual animal (OR = 4.16). As the sample size of
seropositive farms was limited, the power of the study
was not sufficient to identify risk factors with weak
association. Nonetheless, the final model confirms
previous reports that pointed to the relevance of
common housing of sheep and cattle as a main risk
factor [19, 23, 44, 70]. In particular, sheep persistently
infected with BDV pose a considerable risk when
housed together with BVDV-free livestock. In the
course of a BVD eradication scheme, the importance
of interspecies transmission might increase with the
continuous decrease in antibody seroprevalence in
cattle and their ensuing increase in susceptibility to
(re-)infection with pestiviruses [19].
Conclusion
Collectively, our study proposes that farmers with com-
mon housing of cattle and sheep should be aware of inter-
species virus transmission, especially during lambing,
where a high infection pressure exists [71]. In situations
where contact between cattle and sheep cannot be avoided
or minimized, surveillance of pestiviruses in sheep might
be considered [46]. The Swiss eradication program
encompasses only bovines, but not sheep and goats. Thus,
the mean BDV seroprevalence in pestivirus-antibody
positive cattle of at least 6.7% with an increasing trend
between 2012 and 2014 indicates that the serological
surveillance by ELISA, which does not differentiate BVDV
from BDV infections, might be critical. Even though
discrimination by cross-SNT as described in this study is
laborious, it adds to classical epidemiological investiga-
tions and allows the identification of possible sources of
infection, which is of particular importance in the late
phase of an eradication program [37, 48]. In summary, we
determined for the first time the prevalence of BDV in
pestivirus-positive cattle in Switzerland, and we provide
strong evidence that common housing of cattle and sheep
is the most significant risk factor for the interspecies
transmission of BD virus from small ruminants to cattle.
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